Developed a valuation model for ARL’s cutting-edge sepsis diagnostic product “AcuSept”, which was used by the founder and CEO in reaching out to potential investors
Obtained valuation input through research and market analysis
Drafted pro-forma financial statements and business development plan for the use of the company
